4//SEC Filing
Khan Najat 4
Accession 0001601830-25-000084
CIK 0001601830other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:44 PM ET
Size
7.9 KB
Accession
0001601830-25-000084
Insider Transaction Report
Form 4
Khan Najat
DirectorChief R&D Commercial Officer
Transactions
- Tax Payment
Class A Common Stock
2025-05-15$4.25/sh−3,796$16,133→ 708,585 total
Holdings
- 420,226
Stock Option (Right to Buy)
Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 993,944
Stock Option (Right to Buy)
Exercise: $7.34Exp: 2034-08-01→ Class A Common Stock (0 underlying)
Footnotes (3)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F3]This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0002020969
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:44 PM ET
- Size
- 7.9 KB